Press Releases

Sign Up for Email Alerts

Your email:

Follow Us

Press Releases

describe the image

 

2014 June 26

CYTOMEDIX COMPLETES THE SECOND TRANCHE OF THE $35 MILLION CONVERTIBLE DEBT FINANCING WITH DEERFIELD MANAGEMENT COMPANY

2014 May 15

CYTOMEDIX REPORTS 2014 FIRST QUARTER FINANCIAL RESULTS 

2014 May 8

SAVE THE DATE: CMXI: Q1 2014 Financial Results Conference Call - Friday, May 16, 2014, 8:00am EDT

2014 May 5

CYTOMEDIX ANNOUNCES RESULTS OF RECOVER-STROKE PHASE 2 STUDY; PROVIDES UPDATE ON R&D REORGANIZATION AND ONGOING LAUNCH INITIATIVES FOR AUTOLOGEL(TM)

2014 Apr 22

CYTOMEDIX ANNOUNCES TWO AUTOLOGEL® PRESENTATIONS AT THE SYMPOSIUM ON ADVANCED WOUND CARE (SAWC) SPRING MEETING

2014 Apr 7

CYTOMEDIX ANNOUNCES APPOINTMENT OF ANDREW COHEN AS VICE PRESIDENT OF MARKETING 

2014 Apr 3

CYTOMEDIX ANNOUNCES RECEIPT OF USPTO ALLOWANCE FOR PATENT COVERING USE OF ALDH BRIGHT CELLS IN STROKE

2014 Mar 31

CYTOMEDIX REPORTS 2013 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS; ANNOUNCES UP TO $35 MILLION CONVERTIBLE DEBT FINANCING WITH DEERFIELD MANAGEMENT COMPANY 

2014 Mar 31

CYTOMEDIX ANNOUNCES SENIOR MANAGEMENT APPOINTMENTS

2014 Jan 6

CYTOMEDIX ANNOUNCES COMPLETION OF RECOVER-STROKE TRIAL ENROLLMENT AND UPDATE ON BRIGHT CELL TECHNOLOGY 

2013 Dec 2

CYTOMEDIX ANNOUNCES FINAL PAYMENT DECISION FROM THE CENTERS FOR MEDICARE & MEDICAID SERVICES FOR THE AUTOLOGELTM SYSTEM

2013 Nov 12

CYTOMEDIX REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS AND BEGINS SUPPLYING AUTOLOGEL TO TREAT MEDICARE PATIENTS

2013 Nov 5

CMXI: Earnings call Q3 2013 - Wednesday, November 13, 8:00am EST

2013 Sept 18

CYTOMEDIX PROVIDES UPDATE ON REIMBURSEMENT PROGRESS FOR AUTOLOGELTM IN THE HOSPITAL OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (HOPPS)

2013 Sept 17

CYTOMEDIX ANNOUNCES STRATEGIC REORGANIZATION OF RESEARCH AND DEVELOPMENT OPERATIONS 

2013 Aug 7

CYTOMEDIX ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS AND COMMERCIAL PARTNERSHIP FOR ANGEL TECHNOLOGY 

2013 Aug 2

CYTOMEDIX TO HOST SECOND QUARTER FINANCIAL RESULTS - CONFERENCE CALL ON THURSDAY, AUGUST 8, 2013 

2013 July 10

CENTERS FOR MEDICARE AND MEDICAID SERVICES ISSUE PROPOSED PAYMENT RULES AFFECTING AUTOLOGEL FOR CHRONIC NON-HEALING WOUNDS

2013 May 17

CYTOMEDIX TO PRESENT AT THE WORLD STEM CELLS & REGENERATIVE MEDICINE CONGRESS 2013

2013 May 9

CYTOMEDIX REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS 

2013 May 6

CYTOMEDIX TO HOST FIRST QUARTER 2013 FINANCIAL RESULTS CONFERENCE CALL ON FRIDAY, MAY 10, 2013

2013 Apr 10

CYTOMEDIX TO PRESENT AT REGEN MED INVESTOR DAY 2013

2013 Apr 3

CYTOMEDIX ANNOUNCES APPOINTMENT OF STEVEN A. SHALLCROSS AS CHIEF FINANCIAL OFFICER

2013 Mar 18

CYTOMEDIX REPORTS 2012 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

2013 Mar 18

CYTOMEDIX ANNOUNCES CMS ISSUANCE OF REIMBURSEMENT CODING FOR AUTOLOGOUS PRP IN CHRONIC NON-HEALING WOUNDS

2013 Mar 15

CYTOMEDIX TO PRESENT AT THE CANACCORD GENUITY MUSCULOSKELETAL CONFERENCE

2013 Mar 12

CYTOMEDIX TO HOST FOURTH QUARTER AND FISCAL YEAR 2012 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, MARCH 19, 2013

2013 Mar 04

CYTOMEDIX ANNOUNCES CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) APPROVAL OF CLINICAL OUTCOMES IN PROTOCOLS FOR AUTOLOGOUS PRP (AUTOLOGELTM) UNDER COVERAGE WITH EVIDENCE DEVELOPMENT PROGRAM

2013 Feb 20

CYTOMEDIX TO RAISE UP TO $27.5 MILLION AS PART OF A COMPREHENSIVE 2013 FINANCING PLAN

2013 Feb 11

CYTOMEDIX ANNOUNCES APPROVAL OF ANGEL cPRP SYSTEM IN AUSTRALIA

2013 Jan 14

CYTOMEDIX TO PRESENT AT NOBLE FINANCIAL CAPITAL MARKETS EQUITY CONFERENCE ON JANUARY 23rd 2013

2013 Jan 14

FROST & SULLIVAN 2012 NEW PRODUCT INNOVATION AWARD RECOGNIZES CYTOMEDIX ANGEL® cPRP TECHNOLOGY

2012 Dec 6

CYTOMEDIX ANNOUNCES LANDMARK BRIGHT CELL THERAPY STUDY IN PERIPHERAL ARTERIAL DISEASE 

2012 Nov 29

CYTOMEDIX ANNOUNCES CE MARK APPROVAL FOR ANGEL® cPRP SYSTEM FOR PROCESSING BLOOD AND BONE MARROW ASPIRATE

2012 Nov 15

CYTOMEDIX ANNOUNCES THIRD QUARTER 2012 FINANCIAL RESULTS

2012 Nov 9

CYTOMEDIX TO HOST THIRD QUARTER 2012 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, NOVEMBER 15, 2012

2012 Nov 8

ANGEL® cPRP SYSTEM GRANTED FDA 510(K) CLEARANCE FOR PROCESSING BLOOD AND BONE MARROW ASPIRATE

2012 Oct 23

CYTOMEDIX TO PRESENT AT UPCOMING STEM CELL CONFERENCES

2012 Oct 11

CYTOMEDIX ANNOUNCES PRESENTATION OF ALD-401 SAFETY DATA AT THE WORLD STROKE CONGRESS IN BRAZIL

2012 Oct 11

CYTOMEDIX’S AUTOLOGEL™ FEATURED AT NATIVE AMERICAN WOUND CARE CONFERENCE AND DIABETIC LIMB SALVAGE CONFERENCE

2012 Sep 28

CYTOMEDIX ANNOUNCES POSTER PRESENTATION AT BRITISH ASSOCIATION OF AESTHETIC PLASTIC SURGEONS ANNUAL SCIENTIFIC MEETING

2012 Sep 19

Cytomedix to Present at BIOX; Noble Financial Capital Markets’ Life Sciences Exposition

2012 Sep 17

Cytomedix Shares Now Trading on OTCQX

2012 Sep 11

Cytomedix’s AutoloGel System Highlighted in Multiple Poster Presentations at the Symposium on Advanced Wound Care Fall 2012

2012 Sep 05

Cytomedix’s AutoloGel System Highlighted in Two Presentations at the 4th Congress of the World Union of Wound Healing Societies

2012 Sep 04

Cytomedix’s AutoloGel System Featured in Continuing Education Program at the Paralyzed Veterans of America Summit 2012

2012 Aug 14

Cytomedix Reports Second Quarter 2012 Financial Results and Provides Corporate Update

2012 Aug 6 Cytomedix Announces Medicare Coverage for Autologous PRP GEL in Chronic Wound Care
2012 Jul 18 Cytomedix Announces Collaboration with Duke University on Phase I study of ALD-451 in Malignant Glioma
2012 Jul 11 Cytomedix to Webcast, Live, at RetailInvestorConferences.com on July 12th
2012 Jul 2 Cytomedix Announces Extension of Exclusivity Period to Global Pharmaceutical company for AutoloGel System in Chronic Wound Market
2012 Jun 19 Cytomedix Announces Participation at 2012 BIO International Convention
2012 Jun 8 Cytomedix Announces Multiple Poster Presentations at the 44th Annual Conference of the Wound Ostomy Continence Nurses Society
2012 May 16 Cytomedix Announces Expansion of Phase 2 Study to Treat Post-Acute Ischemic Stroke at up to 15 U.S. Clinical Sites
2012 May 15 Cytomedix Reports First Quarter 2012 Financial Results  
2012 May 9 Cytomedix Announces Proposed National Coverage Determination Memo by CMS for Autologous PRP Gel in Chronic Wounds 
2012 May 9 Cytomedix to Host First Quarter 2012 Financial Results Conference Call on Wednesday, May 16, 2012
2012 Apr 18 Cytomedix Announces Multiple Poster Presentations at the Symposium on Advanced Wound Care Spring 2012 Conference
2012 Apr 11 Cytomedix Reports Publication of Positive AutoloGel Wound Healing Data in Ostomy Wound Management
2012 Apr 2 Cytomedix to Present at the 11th Annual Needham Healthcare Conference
2012 Mar 29 Cytomedix Reports 2011 Fourth Quarter and Full Year Financial Results
2012 Mar 20 Cytomedix to Host 2011 Financial Results Conference Call on Friday, March 30, 2012
2012 Mar 15 Cytomedix Announces Publication in American Heart Journal Highlighting Positive Phase I Clinical Data Using ALD-201 to Treat Ischemic Heart Failure
2012 Feb 16 Cytomedix to Showcase Aldagen's Promising Autologous Cell Therapy Technology at Two Regenerative Medicine Meetings
2012 Feb 14 Cytomedix to Present at LHA Life Sciences & Medical Technologies Virtual Conference
2012 Feb 8 Cytomedix Expands Commitment to Regenerative Medicine with Acquisition of Aldagen 
2012 Feb 3 Cytomedix Appoints David E. Jorden as Executive Chairman of the Board
2012 Feb 2 Cytomedix Announces Option Extension With Top 20 Global Pharmaceutical Company and Intent to License Agreement for the AutoloGel System 
2012 Jan 17 Cytomedix Appoints Cathryn Hope as Vice President of Marketing
2012 Jan 3 Cytomedix Offers Short Term Option Extension to Global Pharmaceutical Company for Distribution of AutoloGel System in Chronic Wound Market
2011 Nov 14 Cytomedix Reports Third Quarter Financial Results
2011 Nov 11 CMS Approves Reconsideration Request for Reimbursement of Autologous PRP Gel in Chronic Wound Care
2011 Nov 8 Cytomedix to Host Third Quarter 2011 Financial Results Conference Call on Tuesday, November 15, 2011
2011 Oct 14 Cytomedix Announces Option Agreement with Global Pharmaceutical Company for Distribution of AutoloGel System in Chronic Wound Market
2011 Oct 11 Cytomedix Announces Multiple Presentations at the Symposium on Advanced Wound Care Fall 2011
2011 Sep 22 Cytomedix Announces Publication in EPLASTY of Systematic Review and Meta-Analysis on Use of Platelet Rich Plasma Gel in Wound Healing
2011 Sep 21 Cytomedix Announces Publication of Data from Wound Outcomes Registry in the International Wound Journal
2011 Sep 15 Cytomedix Launches PRP Hair Restoration Wound Care Program at the International Society of Hair Restoration Surgeons Annual Meeting
2011 Sep 08 Cytomedix to Present at Rodman & Renshaw 13th Annual Global Investment Conference
2011 Sep 07 Cytomedix Announces Poster Presentations at the 26th Annual Clinical Symposium on Advances in Skin and Wound Care
2011 Sep 01 Cytomedix Submits 510(k) to FDA for Bone Marrow Aspirate Concentrate Indication for Angel System
2011 Aug 31 Cytomedix Provides Update on Reimbursement Reconsideration Request for Autologous PRP Gel
2011 Aug 15 Cytomedix Reports Second Quarter Financial Results
2011 Aug 09 Cytomedix to Host Second Quarter 2011 Financial Results Conference Call on Tuesday, August 16, 2011
2011 Aug 01 Positive Data Demonstrating AutoloGel Provides Rapid Improvement in Healing of Complex Chronic Wounds Published in Advances in Skin and Wound Care
2011 Aug 01 The Clinical Relevance of Treating Chronic Wounds with an Enhanced Near-Physiological Concentration of Platelet-Rich Plasma Gel
2011 July 20 Cytomedix Completes Two Convertible Note Financings
2011 May 31 Cytomedix Submits Reimbursement Reconsideration Request to Centers for Medicare & Medicaid Services for Autologous PRP Gel
2011 May 16 Cytomedix Reports First Quarter Financial Results
2011 May 11 Cytomedix to Host First Quarter 2011 Financial Results Conference Call On Tuesday, May 17, 2011
2011 May 02 Cytomedix Retires All Angel Acquisition Debt with New Loan and Equity Financing
2011 Apr 13 Cytomedix Announces Multiple Presentations at the 24th Annual Symposium on Advanced Wound Care and Wound Healing Society
2011 Mar 30 Cytomedix Reports 2010 Fourth Quarter and Full Year Financial Results
2011 Mar 17 Cytomedix Announces Issuance of Notice of Allowance for Patent Covering Separation Device for Proposed New AutoloGel System
2011 Mar 16 Cytomedix to Host Fourth Quarter and Full Year 2010 Financial Results Conference Call On Thursday, March 31, 2011
2011 Mar 10 Cytomedix Appoints Gary R. Otto as Director of National Accounts
2011 Feb 15 Cytomedix to Present at the Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on February 17
2011 Feb 10 Cytomedix Receives CE Mark for Angel and activAT
2011 Feb 02 Cytomedix CEO Issues Shareholder Update
2011 Jan 27 Cytomedix Provides Clarification for Investors Concerning Trading under New Stock Symbol of CMXI
2011 Jan 25 Cytomedix To Begin Trading Under New Symbol—CMXI—Effective January 26, 2011
2011 Jan 21 Cytomedix Common Stock to Trade on the OTC Bulletin Board
2011 Jan 06 Cytomedix Announces Restatement of Financial Statements Related to Equity Accounting Treatment for Previously Issued Warrants
2011 Jan 06 Cytomedix to Present at 4th Annual OneMedForum San Francisco 2011 Conference
2010 Dec 22 Cytomedix ’s Japanese Partner Compiles Data on 100 Wounds Treated with AutoloGel System
2010 Dec 07 Cytomedix Receives ISO 13485 and Canadian Medical Device Certifications
2010 Dec 06 Cytomedix Announces Formation of Scientific Advisory Board
2010 Nov 19 Cytomedix to Appeal Delisting Determination by NYSE Amex LLC
2010 Nov 18 Cytomedix to Present AutoloGel System Data at the Desert Foot Conference 2010
2010 Nov 10 Cytomedix Third Quarter Results Feature Record Product Revenue
2010 Nov 08 Cytomedix To Participate in The 2010 Gems in Wound Care Panel Hosted by Rodman and Renshaw
2010 Nov 02 Cytomedix To Host Third Quarter 2010 Financial Results Conference Call On Thursday, November 11, 2010
2010 Oct 08 Cytomedix Secures $13 Million in Committed Funding
2010 Sep 23 Cytomedix Announces AutoloGel System Poster Presentation at the Symposium on Advanced Wound Care (SAWC) Fall 2010
2010 Sep 23 Cytomedix Announces AutoloGel System Oral Presentation at the Academy of Spinal Cord Injury Professionals' Annual Meeting
2010 Sep 07 Cytomedix to Present at Rodman & Renshaw 12th Annual Global Investment Conference
2010 Aug 16 Cytomedix Reports Second Quarter 2010 Financial Results
2010 Aug 09 Cytomedix To Host Second Quarter 2010 Financial Results Conference Call On Tuesday, August 17, 2010
2010 Jul 28 Cytomedix Appoints Patrick Vanek as Vice President of Operations
2010 Jun 16 Positive Data from Study of the AutoloGel System to Treat Complex Chronic Wounds Published in Ostomy Wound Management
2010 Jun 15 Cytomedix Announces AutoloGel System Poster Presentations at the Wound Ostomy and Continence Nurses Society Conference
2010 Jun 01 Cytomedix to Present at Sixth Annual Noble Financial Equity Conference
2010 May 17 Cytomedix Reports First Quarter Financial Results - Conference Call Begins Tuesday, May 18th at 10:00 a.m. ET
2010 May 06 Cytomedix To Host First Quarter 2010 Financial Results Conference Call On Tuesday, May 18, 2010
2010 Apr 16 Cytomedix Announces Multiple Presentations at the 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society
2010 Apr 12 Link to Cytomedix's Conference call on April 13, 2010 at 10:00 a.m.
2010 Apr 12 Cytomedix Announces Going Concern Qualification
2010 Apr 12 Cytomedix Acquires Angel Whole Blood Separation System and activAT Autologous Thrombin Processing Kit from Sorin Group for $7 Million. Conference Call Begins April 13th at 10:00 a.m. Eastern Time
2010 Mar 29 Cytomedix Reports Fourth Quarter and Full Year Financial Results
2010 Mar 04 Cytomedix To Host Fourth Quarter and Year End 2009 Financial Results Conference Call On Tuesday, March 30, 2010
2010 Feb 23 Cytomedix’s AutoloGel™ System Highlighted in Hair Transplant Trade Journal
2009 Nov 13 Cytomedix Appoints Dr. Craig Mendelsohn to Board of Directors
2009 Nov 11 Cytomedix Reports Third Quarter Financial Results
2009 Oct 30 Cytomedix To Host Third Quarter And Nine Months 2009 Financial Results Conference Call On Thursday, November 12, 2009
2009 Oct 27 Cytomedix to Present at the 8th Annual BIO Investor Forum
2009 Oct 15 Cytomedix to Present at Growth Stock Conference Hosted by Security Research Associates, Inc.
2009 Sept 30 Cytomedix Enters License Agreement with Millennia Holdings for Exclusive Rights to the Autologel System in Japan
2009 Sept 9 Cytomedix CEO Issues Shareholder Update
2009 Aug 27 Cytomedix Announces Subsequent and Final Closing of Registered Direct Offering of Common Stock and Warrants
2009 Aug 25 Cytomedix Announces Registered Direct Offering of Common Stock and Warrants
2009 Aug 10 Cytomedix Second Quarter Financial Results Feature Product Sales Up 72% Over First Quarter
2009 Aug 7 Cytomedix Files Application with FDA for AutoloGel™ System in Orthopedics
2009 Jul 29 Cytomedix Announces Acceptance by NYSE Amex of Plan of Compliance
2009 May 27 Cytomedix Announces the Publication of a New AutoloGel™ Case Series in the Journal Wounds 
2009 May 15 Cytomedix Receives a NYSE Amex Listing Deficiency Notification 
2009 Apr 23 Cytomedix To Exhibit at the 22nd Annual Sympsosium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) Meeting
2009 Apr 09 Cytomedix CEO Discusses the Company and his Leadership Style in an Interview on the Leaders Spot with Rebecca Blacksmith
2009 Mar 31 Cytomedix, Inc. Reports Year-End 2008 Financial Results 
2009 Mar 31 Cytomedix CEO Issues Shareholder Update
2009 Feb 05 Cytomedix Further Strengthens Its Board of Directors
2008 Dec 10 Cytomedix Announces Publication of Economic Model Indicating Cost-Effectiveness of AutoloGel™ for Diabetic Foot Ulcers
2008 Oct 20 Cytomedix To Present At Rodman & Renshaw 10TH Annual Healthcare Conference On Wednesday, Nov. 12, 2008
2008 Sep 19 Cytomedix On Track With Sales and Marketing Efforts For AutoloGel™ System and Further Development of CT-112 Peptide, Annual Meeting Told
2008 Sep 10 Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development
2008 Sep 08 Cytomedix Completes $1.5 Million Capital Raise
2008 Aug 19 Cytomedix CEO Martin Rosendale Discusses Company in Interview with the Wall Street Transcript
    The Wall Street Transcript - August 18, 2008
2008 Jul 28 Cytomedix Retains Dr. David F. Counts, Inventor of Company's Anti-Inflammatory Peptide Patent
2008 Jul 16 Cytomedix CEO Issues Shareholder Update
2008 Jun 12 Cytomedix Unveils Clinical Plans for the Development of Anti-Inflammatory Peptides
2008 Jun 09 Cytomedix Announces Transition of Leadership Martin Rosendale Appointed CEO
2008 May 14 Cytomedix Joins The Acute Long Term Hospital Association (ALTHA) as an Allied Member
2008 May 05 Cytomedix Gains Access To U.S. Government Medical Facilities By Adding The AutoloGel™ System To The Federal Supply Schedule
2008 Apr 22 Cytomedix Provides Update on Efforts to Secure Medicare Reimbursement for Its AutoloGel™ System
2008 Apr 10 Cytomedix to Exhibit at the 21ST Annaul Symposium On Advanced Wound Care (SAWC) April 24-27, 2008
2008 Mar 19 Centers For Medicare And Medicaid Services (CMS) Reaches Final Coverage Decision on PRP GEL
2008 Mar 17 Cytomedix Appoints Martin P. Rosendale Executive Vice President and Chief Operating Officer
2008 Feb 12 The Kon-Lin Letter Initiates New Coverage of Cytomedix In Its February 2008 Issue With Initial Target of $4.50-$5.00 and Ultimate Target of $7-$9
2008 Jan 30 Cytomedix Submits Comments in Response to CMS’ Proposed National Coverage Decision